Latest clinical trials News | Page 19

Potential New Treatment Pathway For Bladder Cancer
Bioxyne (ASX:BXN) Delivers Australia’s First Pharmaceutical Cannabis Gummies Under TGA GMP Licence
Noxopharm targets clinical trial for first-in-class investigative therapy
Dan L Duncan Comprehensive Cancer Center launches Phase 1 Clinical Trial Program
$20 million to establish world-leading clinical trial centre for all NSW residents
New method could lower radiotherapy doses for some cancer patients
Quantitative Ultrasound Parameters Offer New Tool for Diagnosing Lung Disease
Galderma Receives U.S. FDA Approval for Nemluvio® (nemolizumab) for Adult Patients Living With Prurigo Nodularis
FDA rejects MDMA-assisted therapy for PTSD treatment – a drug researcher explains the challenges psychedelics face
Dementia risk factors identified in new global report are all preventable – addressing them could reduce dementia rates by 45%
UniSC to trial a single-dose investigational treatment for coeliac disease
New Australian-designed model for prevention of the world’s leading cause of death
Leadership Role For IRD Innovator
Electric Bandage Holds Promise for Treating Chronic Wounds
How supercharged silk could help heal the heart
Personalised cancer vaccines to be produced at new UQ lab
Associate Professor David Croucher on Triple Negative Breast Cancer
First recipients of the Burnext accelerator program announced
Life-Saving Medical Discovery Centre Hits Major Milestone
Study Finds Reliable Performance For Wireless Pacemaker
Helping Victoria’s Emerging Researchers Make Their Mark
T-cells With License To Kill Viruses
AusBiotech Welcomes More New Members In Second Quarter
Boston Oncology and King Fahd Medical City (KFMC) Partner to Advance Localized Cell & Gene Therapy in Saudi Arabia
BioNet’s Recombinant Pertussis Vaccine Submitted to European Medicines Agency (EMA)
Skin may hold key to neurodevelopmental disorder diagnosis
Biogen, Beckman Coulter and Fujirebio to Collaborate on Blood-Based Biomarkers and Test for Tau Pathology in Alzheimer’s Disease
Galderma’s Relfydess(TM) (RelabotulinumtoxinA) Receives Positive Decision for Use in Europe
Medicaid policies increase diversity in cancer clinical trials
Royal Hobart Hospital pharmacy redevelopment progressing well
Vaccines tell a success story that Robert F. Kennedy Jr. and Trump forget – here are some key reminders
Personalised cancer vaccines to be produced at new UQ lab
Using MRNA Technology To Prevent Cancer And Treat Disease
Nasal spray clears proteins linked to Alzheimer’s – new study
Eisai Selects Medidata’s Clinical Data Studio to Enhance and Modernize Clinical Trial Efficiency and Patient Experience
PHASE III ARCADIA 1 and 2 Trial Primary Results Published in The Lancet: Galderma’s Nemolizumab Improves Key Aspects of Atopic Dermatitis -…
Microsoft collaborates with Mass General Brigham and University of Wisconsin-Madison to further advance AI foundation models for medical imaging
Groundbreaking pre-eclampsia screening test to be trialled
Cranberry juice really can help with UTIs – and reduce reliance on antibiotics
Neuren secures Rare Paediatric Disease Designation from FDA
Gene therapy discovery triggers hope for glaucoma patients
Southern Cross University announces $10 million gift from Blackmore Family Foundation
Minister to speak at Australian Space Forum
Antiretrovirals in Pregnancy Research Toolkit
New tech addresses manufacturing bottlenecks in a lifesaving blood cancer treatment
Medical health research to focus on connection and innovation
NSW Government invests $4.5 million to help reduce and replace animals in medical research
World-first international guidelines weeds-out potentially critical scientific fraud